Tamoxifen-induced radiation recall dermatitis: Three calls from Egypt

Abstract

Tamoxifen is a selective estrogen receptor modulator used for hormone receptor-positive breast cancer in addition to radiotherapy. Tamoxifen-induced radiation recall dermatitis (RRD) was 1^st described in 1992 however only 7 cases have been reported¹. Herein, we report 3 Egyptian patients with tamoxifen-induced RRD to highlight its diagnostic and therapeutic aspects.

This article is protected by copyright. All rights reserved.

http://ift.tt/2ldS1if